CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}
Building-2 Hero banner Building-2 Mobile

Cushman & Wakefield Advises Triple Point Social Housing REIT Plc on Voyage Care portfolio

02/10/2019

Cushman & Wakefield has advised Triple Point Social Housing REIT on its acquisition of Voyage Care’s portfolio of 40 Supported Living properties for £27.4m.

The sale of 36 properties across the UK has been completed, with the remaining four expected to complete within two months following a consultation process with tenants. The deal comprises an initial £24.5m and a deferred amount of up to £2.9m.

Triple Point Social Housing REIT Plc was advised by Sam Gadar of Cushman & Wakefield’s Healthcare Transactions & Advisory team.

Voyage Care had leased the properties to registered providers, who in turn sublet housing units to individual tenants with a variety of support needs, under individual tenancy agreements.

Following the sale, the social housing REIT, which funds the supply of specialised supported housing for vulnerable people in the UK, will own the freehold interest in the properties. However, agreements between registered providers and tenants will remain in place, ensuring continuity for the end user.

Voyage Care will continue to provide specialist support to individual tenants who have learning disabilities, autism, brain injuries or other complex needs, in addition to operating its wider estate of care homes and supported living settings.

Max Shenkman, Head of Investment at Triple Point Investment Management, the fund manager of Triple Point Social Housing REIT, said: “This transaction involves a well-diversified portfolio of assets – both geographically and across housing associations – and a high-quality care provider.

“Properties like this are helping deliver a better quality of life for some of the most vulnerable people in our society whilst saving local authorities money and generating a sustainable financial return for shareholders.”

Sam Gadar from Cushman & Wakefield’s Healthcare team, said: “We were pleased to advise on the acquisition of this high-quality portfolio of supported housing assets. The properties house vulnerable adults and so tenant welfare was prioritised throughout the transaction process. It was a pleasure working with the team at Triple Point Social Housing REIT, who have an excellent understanding of the market and the sensitivities involved in a transaction of this nature.”

The UK Cushman & Wakefield Healthcare Team are part of the Global Cushman & Wakefield Healthcare Division. The team has extensive experience in all market segments covering the Elderly Care, Retirement Living, Medical and Educational segments working with a wide range of clients including operators, investors and developers.

MEDIA CONTACT

Richard Coleman, Head of Communications EMEA
Richard Coleman

Head of EMEA Communications • London

What's new

James Dunne 2024 Headshot.jpg
Cushman & Wakefield Appoints Capital Markets Heavyweight James Dunne As Head Of UK Living

Cushman & Wakefield has continued its expansion in the Living sector with the appointment of capital markets heavyweight James Dunne as its Head of UK Living.

15/11/2024

EMEA_OFFICE SPACES_AdobeStock_604962479.jpeg
Take-Up of London Grade A Office Space Exceeds Pre-Pandemic Levels by 4%

New data from global real estate advisor Cushman & Wakefield highlights the continued and sustained appeal of Grade A office space in Central London, as leasing take-up volumes exceed the pre-pandemic five-year quarterly average by 4% in Q3 2024.

15/11/2024

UK London City
Cushman & Wakefield Appoints New Head of Central London Development

Cushman & Wakefield has appointed Henry Fellows as its new Head of Central London Development.

Lauren Joselyn • 06/11/2024

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Cookies.
MORE OPTIONS
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS